Endothelial dysfunction and inflammation in asymptomatic proteinuria

Kidney International

Volumn 63, Issue 2, 2003, Pages 624-633

  Paisley, Karen E ^a,b,c   Beaman, Martin ^a,b   Tooke, John E ^a,b   Mohamed Ali, Vidya ^a,b   Lowe, Gordon D O ^a,b   Shore, Angela C ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c PENINSULA MEDICAL SCHOOL   (United Kingdom)

Author keywords

Brachial artery ultrasound; C reactive protein; Endothelial function; Inflammation; Iontophoresis; Proteinuria; Von Willebrand factor

Indexed keywords

ACETYLCHOLINE; C REACTIVE PROTEIN; VON WILLEBRAND FACTOR;

ADULT; ANALYTIC METHOD; ARTICLE; BRACHIAL ARTERY; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOTHELIUM; FEMALE; HEATING; HUMAN; HYPEREMIA; INFLAMMATION; IONTOPHORESIS; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEINURIA; ULTRASOUND;

EID: 0037245519     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2003.00768.x     Document Type: Article

References (68)

1. MOGENSEN CE: Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 310:356-360, 1984
2. KANNEL WB, STAMPFER MJ, CASTELLI WP, VERTER J: The prognostic significance of proteinuria: The Framingham study. Am Heart J 108:1347-1352, 1984
3. YUDKIN JS, FORREST RD, JACKSON CA: Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey. Lancet 2:530-533, 1988
4. LEWIS DM, BRADWELL AR, SHORE AC, et al: Capillary filtration coefficient and urinary albumin leak at altitude. Eur J Clin Invest 27:64-68, 1997
5. LEWIS DM, TOOKE JE, BEAMAN M, et al: Peripheral microvascular parameters in nephrotic syndrome. Kidney Int 54:1261-1266, 1998
6. JENSEN JS, BORCH-JOHNSEN K, JENSEN G, FELDT-RASMUSSEN B: Microalbuminuria reflects a generalised transvascular albumin leakiness in clinically healthy subjects. Clin Sci Lond 88:629-633, 1995
7. ROSS R: The pathogenesis of atherosclerosis - An update. N Engl J Med 8:488-500, 1986
8. BLUM MS, TONINELLI E, ANDERSON JM, et al: Cytoskeletal rearrangement mediates human microvascular endothelial tight junction modulation by cytokines. Am J Physiol 273:H286-H294, 1997
9. MICHEL CC: Transport of macromolecules through microvascular walls. Cardiovasc Res 32:644-653, 1996
10. RAZANI B, ENGELMAN JA, WANG XB, et al: Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J Biol Chem 276:38121-38138, 2001
11. SCHUBERT W, FRANK PG, RAZANI B, et al: Caveolae-deficient endothelial cells show defects in the uptake and transport of albumin in vivo. J Biol Chem 276:48619-48622, 2001
12. VOGEL SM, EASINGTON CR, MINSHALL RD, et al: Evidence of transcellular permeability pathway in microvessels. Microvasc Res 61:87-101, 2001
13. DRAB M, VERKADE P, ELGER M, et al: Loss of caveolae, vascular dysfunction and pulmonary defects in caveolin-1 gene-disrupted mice. Science 293:2404-2405, 2001
14. CLAUSEN P, JENSEN JS, JENSEN G, et al: Elevated urinary albumin excretion is associated with impaired arterial dilatory capacity in clinically healthy subjects. Circulation 103:1869-1874, 2001
15. HERNANDEZ E, TOLEDO T, ALAMO C, et al: Elevation of von Willebrand factor levels in patients with IgA nephropathy: Effect of ACE inhibition. Am J Kidney Dis 30:397-403, 1997
16. JENSEN JS, MYRUP B, BORCH-JOHNSEN K, et al: Aspects of haemostatic function in healthy subjects with microalbuminuria - A potential atherosclerotic risk factor. Thromb Res 77:423-430, 1995
17. FUSTER V, BADIMON L, BADIMON JJ, CHESEBRO JH: The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N Engl J Med 326:242-250, 1992
18. NABEL EG, SELWYN AP, GANZ P: Large coronary arteries in humans are responsive to changing blood flow: An endothelium-dependent mechanism that fails in patients with atherosclerosis. J Am Coll Cardiol 16:349-356, 1990
19. LUDMER PL, SELWYN AP, SHOOK TL, et al: Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 315:1046-1051, 1986
20. CELERMAJER DS, SORENSEN KE, GOOCH VM, et al: Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340:1111-1115, 1992
21. ADAMS MR, CELERMAJER DS: Detection of presymptomatic atherosclerosis: A current perspective. Clin Sci Lond 97:615-624, 1999
22. ROSS R: Atherosclerosis - An inflammatory disease. N Engl J Med 340:115-126, 1999
23. LIUZZO G, BIASUCCI LM, GALLIMORE JR, et al: The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med 331:417-424, 1994
24. BIASUCCI LM, VITELLI A, LIUZZO G, et al: Elevated levels of interleukin-6 in unstable angina. Circulation 94:874-877, 1996
25. HAVERKATE F, THOMPSON SG, PYKE SD, et al: Production of C-reactive protein and risk of coronary events in stable and unstable angina: European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancet 349:462-466, 1997
26. MORROW DA, RIFAI N, ANTMAN EM, et al: C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: A TIMI 11A sub-study: Thrombolysis in Myocardial Infarction. J Am Coll Cardiol 31:1460-1465, 1998
27. RIDKER PM, CUSHMAN M, STAMPFER MJ, et al: Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336:973-979, 1997
28. KOENIG W, SUND M, FROHLICH M, et al: C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: Results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Ausburg Cohort Study, 1984 to 1992. Circulation 99:237-242, 1999
29. NOON JP, HAYNES WG, WEBB DJ, SHORE AC: Local inhibition of nitric oxide generation in man reduces blood flow in finger pulp but not in hand dorsum skin. J Physiol 490:501-508, 1996
30. LUSCHER TF, BARTON M: Biology of the endothelium. Clin Cardiol 20(11 Suppl 2):II-3-II-10, 1997
31. LIP GY, BLANN A: von Willebrand factor: a marker of endothelial dysfunction in vascular disorders? Cardiovasc Res 34:255-265, 1997
32. FURCHGOTT RF, ZAWADZKI JV: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288:373-376, 1980
33. MORRIS SJ, SHORE AC, TOOKE JE: Responses of the skin microcirculation to acetylcholine and sodium nitroprusside in patients with NIDDM. Diabetologia 38:1337-1344, 1995
34. GROSSMANN M, JAMIESON MJ, KELLOGG DLJ, et al: The effect of iontophoresis on the cutaneous vasculature: Evidence for current-induced hyperemia. Microvasc Res 50:444-452, 1995
35. TENLAND T, SALERUD EG, NILSSON GE, OBERG PA: Spatial and temporal variations in human skin blood flow. Int J Microcirc Clin Exp 2:81-90, 1983
36. RAYMAN G, WILLIAMS SA, SPENCER PD, et al: Impaired microvascular hyperaemic response to minor skin trauma in type I diabetes. Br Med J (Clin Res Ed) 292:1295-1298, 1986
37. WILLIAMS SA, TOOKE JE: Noninvasive estimation of increased structurally-based resistance to blood flow in the skin of subjects with essential hypertension. Int J Microcirc Clin Exp 11:109-116, 1992
38. RUBANYI GM, ROMERO JC, VANHOUTTE PM: Flow-induced release of endothelium-derived relaxing factor. Am J Physiol 250:H1145-H1149, 1986
39. LAURENT S, LACOLLEY P, BRUNEL P, et al: Flow-dependent vasodilation of brachial artery in essential hypertension. Am J Physiol 258:H1004-H1011, 1990
40. SORENSEN KE, CELERMAJER DS, SPIEGELHALTER DJ, et al: Noninvasive measurement of human endothelium dependent arterial responses: Accuracy and reproducibility. Br Heart J 74:247-253, 1995
41. ADAMS MR, ROBINSON J, SORENSEN KE, et al: Normal ranges for brachial artery flow-mediated dilatation: A non-invasive ultrasound test of arterial endothelial function. J Vasc Invest 2:146-150, 1996
42. CHAUVEAU M, LEVY B, DESSANGES JF, et al: Quantitative Doppler blood flow measurement method and in vivo calibration. Cardiovasc Res 19:700-706, 1985
43. CASINO PR, KILCOYNE CM, CANNON RO JR, et al: Impaired endothelium-dependent vascular relaxation in patients with hypercholesterolaemia extends beyond the muscarinic receptor. Am J Cardiol 75:40-44, 1995
44. TOOKE JE, MORRIS SJ, SHORE AC: Microvascular functional abnormalities in diabetes: The role of the endothelium. Diabetes Res Clin Pract 31(Suppl):S127-S132, 1996
45. SHORE AC, TOOKE JE: Microvascular function in human essential hypertension. J Hypertens 12:717-728, 1994
46. THAMBYRAJAH J, LANDRAY MJ, MCGLYNN FJ, et al: Abnormalities of endothelial function in patients with predialysis renal failure. Heart 83:205-209, 2000
47. VAN GULDENER C, JANSSEN MJ, LAMBERT J, et al: Endothelial-dependent vasodilatation is impaired in peritoneal dialysis patients. Nephrol Dial Transplant 13:1782-1786, 1998
48. POHL U, HOLTZ J, BUSSE R, BASSENGE E: Crucial role of endothelium in the vasodilator response to increased flow in vivo. Hypertension 8:37-44, 1986
49. DOSHI SN, NAKA KK, PAYNE N, et al: Flow-mediated dilatation following wrist and upper arm occlusion in humans: The contribution of nitric oxide. Clin Sci Lond 101:629-635, 2001
50. MONCADA S, PALMER RM, HIGGS EA: Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol Rev 43:109-142, 1991
51. COOKE JP, TSAO PS: Is NO an endogenous antiatherogenic molecule? Arterioscler Thromb 14:653-655, 1994
52. QUYYUMI AA, DAKAK N, MULCAHY D, et al: Nitric oxide activity in the atherosclerotic human coronary circulation. J Am Coll Cardiol 29:308-317, 1997
53. KUBES P, GRANGER DN: Nitric oxide modulates microvascular permeability. Am J Physiol 262:H611-H615, 1992
54. JOHNSTON B, GABOURY JP, SUEMATSU M, KUBES P: Nitric oxide inhibits microvascular protein leakage induced by leucocyte adhesion-independent and adhesion-dependent inflammatory mediators. Microcirculation 6:153-162, 1999
55. YUAN Y, GRANGER HJ, ZAWIEJA DC, et al: Histamine increases venular permeability via a phospholipase C-NO synthase-guanylate cyclase cascade. Am J Physiol 264:H1734-H1739, 1993
56. STROES ES, JOLES JA, CHANG PC, et al: Impaired endothelial function in patients with nephrotic range proteinuria. Kidney Int 48:544-550, 1995
57. JOLES JA, STROES ES, RABELINK TJ: Endothelial function in proteinuric renal disease. Kidney Int 71(Suppl):S57-S61, 1999
58. SERNE EH, GANS RO,TER MAATEN JC, et al: Capillary recruitment is impaired in essential hypertension and relates to insulin's metabolic and vascular actions. Cardiovasc Res 49:161-168, 2001
59. KHAN F, LITCHFIELD SJ, STONEBRIDGE PA, BELCH JJ: Lipid-lowering and skin vascular responses in patients with hypercholesterolaemia and peripheral arterial obstructive disease. Vasc Med 4:233-238, 1999
60. KHAN F, DAVIDSON NC, LITTLEFORD RC, et al: Cutaneous vascular responses to acetylcholine are mediated by a prostanoid-dependent mechanism in man. Vasc Med 2:82-86, 1997
61. NOON JP, WALKER BR, HAND MF, WEBB DJ: Studies with iontophoretic administration of drugs to human dermal vessels in vivo: Cholinergic vasodilatation is mediated by dilator prostanoids rather than nitric oxide. Br J Clin Pharmacol 45:545-550, 1998
62. DIETZ NM, RIVERA JM, EGGENER SE, et al: Nitric oxide contributes to the rise in forearm blood flow during mental stress in humans. J Physiol 480:361-368, 1994
63. MORRIS SJ, SHORE AC: Skin blood flow responses to the iontophoresis of acetylcholine and sodium nitroprusside in man: Possible mechanisms. J Physiol 496:531-542, 1996
64. SCHALKWIJK CG, POLAND DC, VAN DIJK W, et al: Plasma concentration of C-reactive protein is increased in type 1 diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: Evidence for chronic inflammation. Diabetologia 42:351-357, 1999
65. FESTA A, D'AGOSTINO R, HOWARD G, et al: Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study. Kidney Int 58:1703-1710, 2000
66. FICHTLSCHERER S, ROSENBERGER G, WALTER DH, et al: Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease. Circulation 102:1000-1006, 2000
67. CLELAND SJ, SATTAR N, PETRIE JR, et al: Endothelial dysfunction as a possible link between C-reactive protein levels and cardiovascular disease. Clin Sci 98:531-535, 2000
68. HAABER AB, EIDEMAK I, JENSEN T, et al: Vascular endothelial cell function and cardiovascular risk factors in patients with renal failure. J Am Soc Nephrol 5:1581-1584, 1995